Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report.

A 41-year-old hyperthyroid woman visited the hospital in April 1989. She spontaneously developed hypothyroidism in August 1989 and recurrent hyperthyroidism in November 1991. TSH binding inhibitor immunoglobulins (TBII) and thyroid-stimulating antibodies (TSAb) activities were 34.7% (normal range, < 11.0%) and 295.0% (normal range, < 145.0%), respectively, at her first visit. When she was hypothyroid, TBII were 85.9-90.0%, TSAb were 75-190%, and thyroid stimulation-blocking antibodies (TSBAb) activities were 80.0-96.6% (normal range, < 32.2%). When she became hyperthyroid again, TSAb activities were markedly increased to 1108% with TBII and TSBAb activities being 82.2 and 62.8%, respectively. The results indicate that both stimulating and blocking types of TSH receptor antibodies were present in her serum and that her fluctuating thyroid function could be explained by alterations in the balance between the activities of these two types of antibodies.

[1]  T. Aizawa,et al.  Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. , 1992, The New England journal of medicine.

[2]  O. Sadeh,et al.  Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper‐thyroidism and back to hypothyroidism , 1992, Clinical endocrinology.

[3]  K. Kuma,et al.  Thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies during the pregnancy and postpartum period: a case report. , 1992, Thyroid : official journal of the American Thyroid Association.

[4]  N. Takasu,et al.  Graves' Disease Following Hypothyroidism Due To Hashimoto's Disease: Studies Of Eight Cases , 1990, Clinical endocrinology.

[5]  S. Nagataki,et al.  Follow‐Up Study Of Thyroid Stimulating‐Blocking Antibodies In Hypothyroid Patients , 1990, Clinical endocrinology.

[6]  N. Amino,et al.  Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. , 1990, The Journal of clinical endocrinology and metabolism.

[7]  S. Fukata,et al.  Transient postpartum hypothyroidism caused by thyroid-stimulation-blocking antibody , 1990, The Lancet.

[8]  J. Mckenzie,et al.  Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. , 1990, The Journal of clinical endocrinology and metabolism.

[9]  H. Hatabu,et al.  PRESENCE OF BOTH STIMULATING AND BLOCKING TYPES OF TSH‐RECEPTOR ANTIBODIES IN SERA FROM THREE PATIENTS WITH PRIMARY HYPOTHYROIDISM , 1990, Clinical endocrinology.

[10]  S. Nagataki,et al.  Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. , 1989, The Journal of clinical endocrinology and metabolism.

[11]  A. Miyauchi,et al.  Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism. , 1988, The American journal of medicine.

[12]  H. Hatabu,et al.  Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis. , 1988, The Journal of clinical endocrinology and metabolism.

[13]  H. Kitaoka,et al.  DEVELOPMENT OF HYPERTHYROIDISM FOLLOWING PRIMARY HYPOTHYROIDISM: A CASE REPORT WITH CHANGES IN THYROID‐RELATED ANTIBODIES , 1988, Clinical endocrinology.

[14]  J. Konishi,et al.  Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema. , 1987, The Journal of clinical endocrinology and metabolism.

[15]  J. Konishi,et al.  A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. , 1986, The Journal of clinical endocrinology and metabolism.

[16]  J. Konishi,et al.  Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients. , 1985, Annals of Internal Medicine.

[17]  P. Carayon,et al.  Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system. , 1983, The Journal of clinical endocrinology and metabolism.

[18]  P. Vitti,et al.  Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.